Traduction de «production branch » (Anglais → Français) :

Food Production and Inspection Branch [ Health of Animals Branch | Food Production and Marketing Branch ]

Dairy Products Fees Order [ Order prescribing fees to be paid by users of services provided, and by persons on whom a right or privilege is conferred, by the Food Production and Inspection Branch of the Department of Agriculture and Agri-Food respecting dairy products ]

product line branch [ product line ]

assurance office manager | insurance product development executive | ensurance branch manager | insurance product manager

bundle branch block | BBB | bundle-branch block | bundle branch heart block | bundle-branch heart-block | interventricular block

review video and motion picture production products | screen video and motion picture production products | watch video and motion picture production products | watching video and motion picture production products

arrange sale of video and motion picture production products | supervise sale of video and motion picture production products | coordinate sale of video and motion picture production products | plan sale of video and motion picture production products

Consisting of that part of the City of Toronto described as follows: commencing at the intersection of Victoria Park Avenue with Sunrise Avenue; thence westerly along Sunrise Avenue and its production to the Don River East Branch; thence generally southwesterly along said branch to Taylor Creek; thence generally easterly along said creek to the northeasterly production of Coxwell Boulevard; thence southwesterly along said production and Coxwell Boulevard to Coxwell Avenue; thence southerly along said avenue to Lake Shore Boulevard East; thence in a ...[+++]straight line on a bearing of 210° to Ashbridge’s Bay; thence generally southerly along said bay to its southerly extremity; thence due south to the southerly limit of the City of Toronto; thence generally northeasterly along said limit to the southerly production of Victoria Park Avenue; thence northerly along said production and Victoria Park Avenue to the point of commencement.

With reference to the side effects experienced by those taking the anti-malarial drug mefloquine (Lariam): (a) provide a detailed update on the clinical study of mefloquine (Lariam) announced by the Department of National Defence in 1997, including trial design, subject inclusion/exclusion criteria, numbers of study subjects recruited to date and participating centres; (b) have reviews been undertaken of the side effects experienced by the Australian, British and Dutch forces, if so what were the results and recommendations, and what steps have been undertaken to implement these recommendations; (c) with regard to the mefloquine (Lariam) used for the prophylaxis of Canadian troops deployed to Somalia, what was the nature of the Department of Health ...[+++]'s Health Protection Branch investigations in October 1997 into the failure of the manufacturer to properly supervise and ensure compliance with the Lariam safety monitoring study and the failure of the Department of National Defence to comply with its obligations under the safety monitoring study; (d) with regard to the mefloquine (Lariam) used for the prophylaxis of Canadian troops deployed to Somalia, what was the outcome of the Department of Health's Health Protection Branch investigations in October 1997 into the failure of the manufacturer to properly supervise and ensure compliance with the Lariam safety monitoring study and the failure of the Department of National Defence to comply with its obligations under the safety monitoring study; (e) what is the date of the insert in the mefloquine (Lariam) package used in Canada today; (f) what is the date of the product monograph for mefloquine (Lariam) used in Canada today; (g) have reviews been undertaken of the insert in the mefloquine (Lariam) package and the prescribing information used in Australia, if so what were the results and recommendations of the reviews, and what steps have been taken to implement the recommendations; (h) have reviews been undertaken ...

From the Department of Health: Julia Hill, Acting Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch; Harold Rode, Acting Manager, Vaccines Division, Health Products and Food Branch; Ian MacKay, Unit Head, Special Access Unit, Clinical Trials and Special Access Programme, Senior Medical Advisor Bureau, Therapeutic Products Directorate, Health Products and Food Branch; Supriya Sharma, Director, Marketed Biologicals and Biotechnology Products Division, Marketed Health Products Directorate, Health Products and Food Branch; Maureen Thompson, Manager, Di ...[+++]abetes Program, First Nations and Inuit Health Branch; Georges Nadon, Pharmaceutical Consultant, Non-Insured Health Benefits Program, First Nations and Inuit Health Branch.

From the Department of Health: Julia Hill, Acting Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch; Dr. Peter Ganz, Director, Biologics and Radiopharmaceutical Evaluation Centre, Biologics and Genetic Therapies Directorate, Health Products and Food Branch; Dr. Howard Njoo, Director General, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch.